Health & Personal Care
HIGH
FDA DRUG
Fresenius Kabi Vancomycin Injection Recalled Over Sterility Concerns
Lack of Assurance of Sterility
Fresenius Kabi Compounding
Lack of
Brand hub
Fresenius Kabi Compounding Recalls
5 recalls found for Fresenius Kabi Compounding. Check current safety alerts and related brands before using affected products.
- Active recalls
- 5
- Pages
- 1
Health & Personal Care
HIGH
FDA DRUG
Fresenius Kabi Compounding Recalls Acyclovir Sodium Injection Due to Sterility Risks
Lack of Assurance of Sterility
Fresenius Kabi Compounding
Lack of
Health & Personal Care
HIGH
FDA DRUG
Fresenius Kabi Compounding Issues Recall of Vancomycin Injection
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding
Lack of
Health & Personal Care
HIGH
FDA DRUG
Fresenius Kabi Compounding Recalls Ketamine Injection for Sterility Risk
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding
Lack of
Health & Personal Care
HIGH
FDA DRUG
Fresenius Kabi Compounding Recalls Thiamine Injection Over Sterility Risk
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Fresenius Kabi Compounding
Lack of
Brand Statistics
Total Recalls
5
Pages
1